In a high CD38+ expressing model, the authors were able to demonstrate a significantly increased anti-tumour effect with the [177Lu]Lu-CD38 compared to the [177Lu]Lu-Ig irrelevant [59]. The gene discussed is CD38; the disease is neoplasm.